These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 18711936

  • 1. The effect of corticosteroid usage on the bacterial killing, clearance and nerve damage in leprosy: a prospective cohort study: part 1--study design and baseline findings of 400 untreated multibacillary patients.
    Khambati FA, Shetty VP, Ghate SD, Capadia GD, Pai VV, Ganapati R.
    Lepr Rev; 2008 Jun; 79(2):134-53. PubMed ID: 18711936
    [Abstract] [Full Text] [Related]

  • 2. The effect of corticosteroids usage on bacterial killing, clearance and nerve damage in leprosy; part 3--Study of two comparable groups of 100 multibacillary (MB) patients each, treated with MDT + steroids vs. MDT alone, assessed at 6 months post-release from 12 months MDT.
    Shetty VP, Khambati FA, Ghate SD, Capadia GD, Pai VV, Ganapati R.
    Lepr Rev; 2010 Mar; 81(1):41-58. PubMed ID: 20496569
    [Abstract] [Full Text] [Related]

  • 3. Effect of corticosteroid usage combined with multidrug therapy on nerve damage assessed using nerve conduction studies: a prospective cohort study of 365 untreated multibacillary leprosy patients.
    Capadia GD, Shetty VP, Khambati FA, Ghate SD.
    J Clin Neurophysiol; 2010 Feb; 27(1):38-47. PubMed ID: 20087206
    [Abstract] [Full Text] [Related]

  • 4. The INFIR Cohort Study: assessment of sensory and motor neuropathy in leprosy at baseline.
    Van Brakel WH, Nicholls PG, Das L, Barkataki P, Maddali P, Lockwood DN, Wilder-Smith E.
    Lepr Rev; 2005 Dec; 76(4):277-95. PubMed ID: 16411508
    [Abstract] [Full Text] [Related]

  • 5. The INFIR Cohort Study: investigating prediction, detection and pathogenesis of neuropathy and reactions in leprosy. Methods and baseline results of a cohort of multibacillary leprosy patients in north India.
    van Brakel WH, Nicholls PG, Das L, Barkataki P, Suneetha SK, Jadhav RS, Maddali P, Lockwood DN, Wilder-Smith E, Desikan KV.
    Lepr Rev; 2005 Mar; 76(1):14-34. PubMed ID: 15881033
    [Abstract] [Full Text] [Related]

  • 6. Sensitivity and specificity of nerve palpation, monofilament testing and voluntary muscle testing in detecting peripheral nerve abnormality, using nerve conduction studies as gold standard; a study in 357 patients.
    Khambati FA, Shetty VP, Ghate SD, Capadia GD.
    Lepr Rev; 2009 Mar; 80(1):34-50. PubMed ID: 19472851
    [Abstract] [Full Text] [Related]

  • 7. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK, Sharma P.
    Indian J Lepr; 2008 Mar; 80(3):247-55. PubMed ID: 19432355
    [Abstract] [Full Text] [Related]

  • 8. The occurrence of reactions and impairments in leprosy: experience in the leprosy control program of three provinces in northeastern Thailand, 1987-1995 [correction of 1978-1995]. III. Neural and other impairments.
    Schreuder PA.
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):170-81. PubMed ID: 9728449
    [Abstract] [Full Text] [Related]

  • 9. Comparative study of uniform-MDT and WHO MDT in Pauci and Multi bacillary leprosy patients over 24 months of observation.
    Rao PN, Suneetha S, Pratap DV.
    Lepr Rev; 2009 Jun; 80(2):143-55. PubMed ID: 19743618
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T, Kaur I, Kumar B, Radotra BD, Dogra S.
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [Abstract] [Full Text] [Related]

  • 14. Impairments and Hansen's disease control in Rondônia state, Amazon region of Brazil.
    De Oliveira CR, De Alencar Mde J, De Sena Neto SA, Lehman LF, Schreuder PA.
    Lepr Rev; 2003 Dec; 74(4):337-48. PubMed ID: 14750579
    [Abstract] [Full Text] [Related]

  • 15. Incidence of acute nerve function impairment and reactions in leprosy: a prospective cohort analysis after 5 years of follow-up.
    Richardus JH, Nicholls PG, Croft RP, Withington SG, Smith WC.
    Int J Epidemiol; 2004 Apr; 33(2):337-43. PubMed ID: 15082636
    [Abstract] [Full Text] [Related]

  • 16. Impairments in multibacillary leprosy; a study from Brazil.
    Pimentel MI, Nery JA, Borges E, Gonçalves RR, Sarno EN.
    Lepr Rev; 2004 Jun; 75(2):143-52. PubMed ID: 15282965
    [Abstract] [Full Text] [Related]

  • 17. Pure neuritic leprosy in India: an appraisal.
    Kumar B, Kaur I, Dogra S, Kumaran MS.
    Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):284-90. PubMed ID: 15485285
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of a new fixed duration (12 weeks) multi-drug regimen of bactericidal drugs in multibacillary leprosy.
    Tejasvi T, Khaitan BK, Khanna N, Pandhi RK, Singh MK.
    Indian J Lepr; 2006 Sep; 78(4):329-37. PubMed ID: 17402345
    [Abstract] [Full Text] [Related]

  • 19. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
    Kaur I, Dogra S, Kumar B, Radotra BD.
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.